FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/098382 [Registered on: 03/12/2025] Trial Registered Prospectively
Last Modified On: 28/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Preventive
Screening
Process of Care Changes
Behavioral 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study to assess whether clinical pharmacist support can improve health outcomes and medication adherence in patients with cardiovascular disease attending a tertiary care hospital. 
Scientific Title of Study   Impact of Clinical Pharmacist Management Model on Health Outcome and Medication Adherence in Cardiovascular Disease (CVD) Patients attending Tertiary Care Teaching Hospital : A Randomized Clinical Trial. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shifa N Bojgar 
Designation  Post Graduate, Department of Pharmacy Practice 
Affiliation  KLE college of Pharmacy Belagavi 
Address  KLE college of pharmacy, belagavi 4th floor pharmacy practice department, JNMC CAMPUS, Nehru Nagar, Belagavi, Karnataka 590010

Belgaum
KARNATAKA
590010
India 
Phone  08762435674  
Fax    
Email  shifabojgar080@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Satish Karoli 
Designation  assistant professor  
Affiliation  KLE college of Pharmacy Belagavi 
Address  JNMC CAMPUS,KLE college of Pharmacy, pharmacy practice department 4th floor, Nehru Nagar, Belagavi, Karnataka 590010

Belgaum
KARNATAKA
590010
India 
Phone  9964501059  
Fax    
Email  satishkaroli@klepharm.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Satish Karoli 
Designation  assistant professor  
Affiliation  KLE college of Pharmacy Belagavi 
Address  JNMC CAMPUS,KLE college of Pharmacy, pharmacy practice department 4th floor, Nehru Nagar, Belagavi, Karnataka 590010

Belgaum
KARNATAKA
590010
India 
Phone  9964501059  
Fax    
Email  satishkaroli@klepharm.edu  
 
Source of Monetary or Material Support  
nil 
 
Primary Sponsor  
Name  KLE College of Pharmacy, Belagavi - 590010  
Address  JNMC CAMPUS, Nehru Nagar, Belagavi, Karnataka 590010 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Shifa N Bojgar  KLEs Dr. Prabhakar Kore Hospital & Medical Research Centre, Belagavi  Front Entrance, NH Service Road, Cardiology department 2nd floor Nehru Nagar, Belagavi, Karnataka 590010
Belgaum
KARNATAKA 
8762435674

bojgarshifa13@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
KLECOPBGM ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I110||Hypertensive heart disease with heart failure,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Education on disease managemant and medicines  screening patients with high blood pressure and educating them with diet ,physical activity and medication adherence.  
Comparator Agent  prescription as per doctor advice no intervention is given   advising patients with prescriptions 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1.Patients Diagnosed With CVD.
2.Patients With The Age more than 18years.
3.Patients Admitted In General Medicine And Cardiology Department IPD and OPD. 
 
ExclusionCriteria 
Details  1.Pregnant And Lactating Women Will Be Excluded.
2.Psychiatric Patients And Patients Having Terminal Illness Will Be Excluded.
3.Inability Of Patients To Participate Due To Physical Limitations.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.To Assess The Impact Of Clinical Pharmacist Management Model On Health Outcomes.
2.To Assess Medication Adherence Using Hill-bone Scale.
 
Baseline to one month
 
 
Secondary Outcome  
Outcome  TimePoints 
To Identify Adverse Drug Reactions (ADRs).
 
Baseline to six months 
 
Target Sample Size   Total Sample Size="186"
Sample Size from India="186" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="7"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This randomized clinical trial aims to evaluate the impact of a Clinical Pharmacist Management Model on health outcomes and medication adherence among patients with cardiovascular disease attending a tertiary care teaching hospital. Cardiovascular disease requires long-term therapy, and poor adherence is a major contributor to treatment failure, complications, and repeated hospitalization. Clinical pharmacists play a key role in optimizing drug therapy, educating patients, and monitoring adherence. 
Close